Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent D835257 Pharmaceutical tablet

Patent D835257 was granted and assigned to Celgene on December, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Celgene

Current Assignee

Celgene

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

D8352570

Patent Inventor Names

Scott Burnside0

Darshan Parikh0

Jiping Liu0

Sreenivas S. Bhat0

Date of Patent

December 4, 2018

Patent Application Number

295948220

Date Filed

February 22, 2017

Patent Citations Received

‌

US Patent D1039677 Pill

‌

US Patent D1017017 Pill

Patent Primary Examiner

‌

Charles D Hanson

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent D835257 Pharmaceutical tablet

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API